[1] BANALES JM,MARIN JJG,LAMARCA A,et al.Cholangiocarcinoma 2020:the next horizon in mechanisms and management[J].Nat Rev Gastroenterol Hepatol,2020,17(9):557-588.
[2] LI JL,JIANG XM,LI CL,et al.LncRNA-MEG3 inhibits cell proliferation and invasion by modulating Bmi1/RNF2 in cholangiocarcinoma[J].J Cell Physiol,2019,234(12):22947-22959.
[3] THIN KZ,TU JC,RAVEENDRAN S.Long non-coding SNHG1 in cancer[J].Clin Chim Acta,2019,494:38-47.
[4] LI ZL,JIANG XM,HUANG LN,et al.Up-regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR-296-5p[J].J Cell Mol Med,2019,23(12):8258-8268.
[5] WAN T,WANG HG,GOU MM,et al.LncRNA HEIH promotes cell proliferation,migration and invasion in cholangiocarcinoma by modulating miR-98-5p/HECTD4[J].Biomed Pharmacother,2020,125:109916.
[6] XIN YJ,HE X,ZHAO W,et al.LncRNA PCAT6 increased cholangiocarcinoma cell proliferation and invasion via modulating miR-330-5p[J].Am J Transl Res,2019,11(9):6185-6195.
[7] ZHANG YB,YU RZ,LI QS,et al.SNHG1/miR-556-5p/TCF12 feedback loop enhances the tumorigenesis of meningioma through Wnt signaling pathway[J].J Cell Biochem,2020,121(2):1880-1889.
[8] QIAN C,YE YY,MAO HX,et al.Downregulated lncRNA-SNHG1 enhances autophagy and prevents cell death through the miR-221/222 /p27/mTOR pathway in Parkinson's disease[J].Exp Cell Res,2019,384(1):111614.
[9] YAN SM,LI H,SHU Q,et al.LncRNA SNHG1 exerts a protective role in cardiomyocytes hypertrophy via targeting miR-15a-5p/HMGA1 axis[J].Cell Biol Int,2020,44(4):1009-1019.
[10]尹裕涵,符洋.核仁小分子RNA宿主基因1在消化系统肿瘤中生物学功能的研究进展[J].肿瘤基础与临床,2018,31(3):274-276.
YIN YH,FU Y.Research progress on biological function of nucleolar small RNA host gene 1 in digestive system tumors[J].Tumor Basic and Clinical,2018,31(3):274-276.
[11] FU Y,YIN YH,PENG SF,et al.Small nucleolar RNA host gene 1 promotes development and progression of colorectal cancer through negative regulation of miR-137[J].Mol Carcinog,2019,58(11):2104-2117.
[12]张延涛,孙勇,张远鹏.lncRNA SNHG12在乳腺癌中的表达水平及临床意义[J].河北医药,2020,42(001):62-65.
ZHANG YT,SUN Y,ZHANG YP.Expression level and clinical significance of lncRNA SNHG12 in breast cancer[J].Hebei Medicine,2020,42(001):62-65.
[13] QIU B,CHEN TL,SUN RQ,et al.Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle[J].EBioMedicine,2019,50:166-177.
[14]戎晓东,陈炫光,蔡维洵,等.长链非编码RNA SNHG11对人肝癌细胞放疗抵抗作用的影响[J].广东医学,2019,40(13):1846-1850.
RONG XD,CHEN XG,CAI WX,et al.Effect of long chain non encoding RNA SNHG11 on the resistance of human hepatoma cells to radiotherapy[J].Guangdong Medicine,2019,40(13):1846-1850.
[15] SHI SL,ZHANG ZH.Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway[J].Neoplasma,2019,66(5):756-765.